{
	"results": [
		{
			"title": "Danielle M. Carrick, PhD, MHS - Program Director, GEB | EGRP/DCCPS/NCI/NIH",
			"url": "https://epi.grants.cancer.gov/staff/carrick.html",
			"contentType": null,
			"description": "Danielle Mercatante Carrick, Ph.D., M.H.S., is a Program Director in the Genomic Epidemiology Branch in the Epidemiology and Genomics Research Program at NCI."
		},
		{
			"title": "Essential gene network suggests potential therapy for adult T-cell leukemia/lymphoma | Center for Cancer Research - National Cancer Institute",
			"url": "https://ccr.cancer.gov/news/article/essential-gene-network-suggests-potential-therapy-for-adult-t-cell-leukemia-lymphoma",
			"contentType": null,
			"description": "A new study by Louis Staudt, M.D., Ph.D., has uncovered the critical importance of a complex of proteins, called BATF3 and IRF4, in regulating a pro-growth and survival network in adult T-cell leukemia/lymphoma (ATLL). The results demonstrate that this network can be targeted with a class of drugs known as bromodomain-and-extra-terminal-domain (BET) inhibitors, suggesting a"
		},
		{
			"title": "Renewed research focus on the human T-cell leukemia virus | Center for Cancer Research - National Cancer Institute",
			"url": "https://ccr.cancer.gov/news/article/renewed-research-focus-on-the-human-t-cell-leukemia-virus",
			"contentType": null,
			"description": "Human T-cell leukemia virus-1(HTLV-1) is the only known retrovirus to directly cause cancer in humans. Infection with this retrovirus affects millions of people worldwide, but currently there is neither a targeted antiretroviral therapy nor a vaccine available. “The discovery of novel preventive or therapeutic remedies for this retrovirus could relieve not only the suffering"
		},
		{
			"title": "996402: CM: CAPI A Medical History Questionnaire",
			"url": "https://dceg.cancer.gov/tools/design/questionnaires/medical-history/non-hodgkin-lymphoma-medical-history-long-form-questionnaire",
			"contentType": null,
			"description": null
		},
		{
			"title": "2017 ICD-10-CM Casefinding List",
			"url": "https://seer.cancer.gov/tools/casefinding/case2017-icd10cm.html",
			"contentType": null,
			"description": "Comprehensive 2017 ICD-10-CM Casefinding Code List for Reportable Tumors (codes and explanations). Plus supplemental list of codes to screen for as time allows (to increase casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases)."
		},
		{
			"title": "2016 ICD-10-CM Casefinding List",
			"url": "https://seer.cancer.gov/tools/casefinding/case2016-icd10cm.html",
			"contentType": null,
			"description": "Comprehensive 2016 ICD-10-CM Casefinding Code List for Reportable Tumors (codes and and explanations). Plus supplemental list of codes to screen for as time allows (to increase casefinding for benign brain and CNS, hematopoietic neoplasms, and other reportable diseases)."
		},
		{
			"title": "2018 ICD-10-CM Casefinding List",
			"url": "https://seer.cancer.gov/tools/casefinding/case2018-icd10cm.html",
			"contentType": null,
			"description": null
		},
		{
			"title": "FNL HIV Investigator Brandon Keele Shapes Peer Research with Multiple Seminal and Highly Cited Papers | Frederick National Laboratory for Cancer Research",
			"url": "https://frederick.cancer.gov/news/fnl-hiv-investigator-brandon-keele-shapes-peer-research-multiple-seminal-and-highly-cited",
			"contentType": null,
			"description": "Discoveries by AIDS researcher Brandon F. Keele, Ph.D. have not only put him on the leading edge of research to prevent and treat HIV infection. He’s also influenced the work of his peers. Keele, a principal investigator and senior principal scient"
		},
		{
			"title": "Grant R01CA203950 | Division of Cancer Prevention",
			"url": "https://prevention.cancer.gov/research-groups/community-oncology-and-prevention-trials/grants/R01CA203950",
			"contentType": null,
			"description": "The Division of Cancer Prevention (DCP) conducts and supports research to determine a person's risk of cancer and to find ways to reduce the risk. This knowledge is critical to making progress against cancer because risk varies over the lifespan as genetic and epigenetic changes can transform healthy tissue into invasive cancer."
		},
		{
			"title": "Top HIV/AIDS Researcher Elected Fellow of American Academy of Microbiology | Frederick National Laboratory for Cancer Research",
			"url": "https://frederick.cancer.gov/news/top-hivaids-researcher-elected-fellow-american-academy-microbiology",
			"contentType": null,
			"description": "FREDERICK, Md. -- As a deadly mystery disease with an unknown etiology caused worldwide panic in the early 1980s and quickly became an epidemic, Dr. Jeffrey Lifson was right in the middle of it.  He was a recent medical school graduate and cellular "
		},
		{
			"title": "Dr. Jeffrey Lifson Elected Fellow of American Academy of Microbiology | Frederick National Laboratory for Cancer Research",
			"url": "https://frederick.cancer.gov/news/dr-jeffrey-lifson-elected-fellow-american-academy-microbiology",
			"contentType": null,
			"description": "As a deadly mystery disease with an unknown etiology caused worldwide panic in the early 1980s and quickly became an epidemic, Dr. Jeffrey Lifson was right in the middle of it.  He was a recent medical school graduate and cellular immunology fellow "
		},
		{
			"title": "(Updated) BDP Launches Its First Cell Therapy Program | Poster",
			"url": "https://ncifrederick.cancer.gov/about/theposter/content/updated-bdp-launches-its-first-cell-therapy-program",
			"contentType": null,
			"description": "A team from the Biopharmaceutical Development Program is developing a new autologous cell therapy line that uses engineered chimeric antigen receptor T cells to treat acute myeloid leukemia, a particularly aggressive form of pediatric blood cancer. This foray into cell immunotherapy represents a new avenue of research and development for the BDP, which has traditionally"
		},
		{
			"title": "Frederick National Laboratory's Biopharma Development Program Set to Manufacture CAR-T Cell Therapy | Frederick National Laboratory for Cancer Research",
			"url": "https://frederick.cancer.gov/news/FNL-biopharma-dev-program-to-manufacture-car-t-cell-therapy",
			"contentType": null,
			"description": "A team from the Frederick National Laboratory’s Biopharmaceutical Development Program is developing a new autologous cell therapy line that uses engineered chimeric antigen receptor (CAR) T cells to treat acute myeloid leukemia, a particularly ag"
		},
		{
			"title": "SEER Hematopoietic and Lymphoid Neoplasm Database",
			"url": "https://seer.cancer.gov/seertools/hemelymph/51f6cf59e3e27c3994bd5441/",
			"contentType": null,
			"description": null
		},
		{
			"title": "2009-0516: Chronic Inflammation and Risk of Lung Cancer - Approved Projects - The Cancer Data Access System",
			"url": "https://cdas.cancer.gov/approved-projects/401/",
			"contentType": null,
			"description": null
		},
		{
			"title": "Grant R01CA203950 | Division of Cancer Prevention",
			"url": "https://prevention.cancer.gov/major-programs/supportive-care-and-symptom-management/grants/R01CA203950",
			"contentType": null,
			"description": "The Division of Cancer Prevention (DCP) conducts and supports research to determine a person's risk of cancer and to find ways to reduce the risk. This knowledge is critical to making progress against cancer because risk varies over the lifespan as genetic and epigenetic changes can transform healthy tissue into invasive cancer."
		},
		{
			"title": "From father to daughter: A bone marrow transplant for GATA2 deficiency | Center for Cancer Research - National Cancer Institute",
			"url": "https://ccr.cancer.gov/news/article/from-father-to-daughter-a-bone-marrow-transplant-for-gata2-deficiency",
			"contentType": null,
			"description": "James and Jahleel are a father-daughter duo from Tennessee who came to NIH for Jahleel’s bone marrow transplant. Jahleel was diagnosed with GATA2 deficiency, a rare genetic disease that causes a wide range of symptoms, including myeloid leukemias. "
		},
		{
			"title": "COMPREHENSIVE ICD-9-CM CASEFINDING LIST FOR REPORTABLE TUMORS",
			"url": "https://seer.cancer.gov/tools/casefinding/fy2011_cod_casefindinglist_long.pdf",
			"contentType": null,
			"description": null
		},
		{
			"title": "PowerPoint Presentation",
			"url": "https://ncifrederick.cancer.gov/events/conferences/sites/default/files/inline-files/LaiMDS%20NIH%20talk%207.12.19%20final%20%28003%29.pdf",
			"contentType": null,
			"description": null
		},
		{
			"title": "COMPREHENSIVE ICD-9-CM CASEFINDING LIST FOR REPORTABLE TUMORS",
			"url": "https://seer.cancer.gov/tools/casefinding/fy2011_cod_casefindinglist_short.pdf",
			"contentType": null,
			"description": null
		}
	],
	"totalResults": 177
}
